Norway· NO-ID_F395FDA1-4A1C-4855-9571-70CC799DB98F
Rifater
A rifampicin, pyrazinamide and isoniazid product containing isoniazid + pyrazinamide + rifampicin, registered in Norway by Sanofi-aventis. The same ATC class is registered in 6 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Rifampicin, pyrazinamide and isoniazid is registered in 6 of 19 countries.
Countries holding a registration under ATC J04AM05 (rifampicin, pyrazinamide and isoniazid), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 4 of them publish a price we can compare per daily dose
Rifampicin, pyrazinamide and isoniazid · ATC J04AM05
6 / 19 countries
- Czechiaprice
- Finlandprice
- Ireland
- Norwayprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FEST (Norway)- Active substance
- Isoniazid + Pyrazinamide + Rifampicin
- Manufacturer
- Sanofi-aventis
- Country
- Norway (NO)
- ATC code
- J04AM05
- ATC class
- Rifampicin, pyrazinamide and isoniazid
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_F395FDA1-4A1C-4855-9571-70CC799DB98F
- no_varenummer27109660
- gtin3400932993536
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
61 interactions on record for rifampicin, pyrazinamide and isoniazid.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rifampicin, pyrazinamide and isoniazid · interactions on record
61 records
61 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Rifampicin, pyrazinamide and isoniazid in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomRifater tabletsSanofi
- SpainRIFATER COMPRIMIDOS RECUBIERTOSSanofi Aventis S.A.
- FinlandRimcureSandoz A/S
- FranceRIFATER, comprimé enrobéSANOFI WINTHROP INDUSTRIE
- IrelandRifater 50 mg/300 mg/120 mg TabletsSanofi-Aventis Ireland Limited T/A SANOFI
- SwitzerlandRifater, comprimés enrobésSanofi-Aventis (Suisse) SA
- SwedenRimcure 150 mg/75 mg/400 mg Filmdragerad tablettSandoz A/S
- CzechiaRIFAMPICIN 75MG + ISONIAZID 50MG + PYRAZINAMIDE 150MG
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Spain · Rifater
- France · Rifater
- United Kingdom (Northern Ireland) · Rifater
- Ireland · Rifater
- Italy · Rifater
- Portugal · Rifater
- Sweden · Rimcure
- Slovenia · Rifater
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a3601ac2-562d-49a5-91be-288ceaa48250 GET /v1/drugs/a3601ac2-562d-49a5-91be-288ceaa48250?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett, drasjert",
"source": "fest",
"status": "A",
"atc_name": "Rifampicin, pyrazinamid og isoniazid",
"merkevare_id": "ID_F395FDA1-4A1C-4855-9571-70CC799DB98F",
"name_form_strength": "Rifater tab 50 mg/120 mg/300 mg",
"prescription_group": "C"
}See everything about rifampicin, pyrazinamide and isoniazid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.